| Bioactivity | JTP-103237 is a MGAT2 inhibitor (IC50: 0.019 μM and 6.423 μM for hMGAT2 and hMGAT3 respectively). JTP-103237 modulates fat absorption, decreases plasma glucose levels and prevents diet-induced obesity[1]. |
| Name | JTP-103237 |
| CAS | 1883864-16-1 |
| Formula | C24H29F3N6O |
| Molar Mass | 474.52 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Okuma C, et al. JTP-103237, a novel monoacylglycerol acyltransferase inhibitor, modulates fat absorption and prevents diet-induced obesity. Eur J Pharmacol. 2015 Jul 5;758:72-81. |
JTP-103237
CAS: 1883864-16-1 F: C24H29F3N6O W: 474.52
JTP-103237 is a MGAT2 inhibitor (IC50: 0.019 μM and 6.423 μM for hMGAT2 and hMGAT3 respectively). JTP-103237 modulates
Data collection：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.